ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recs

1
Player Avatar SmallPimpin (92.97) Submitted: 9/1/2009 1:00:17 PM : Outperform Start Price: $1.95 ACAD Score: -62.54

Mmm...biopharmaceuticals...

Featured Broker Partners


Advertisement